Europe is often the center of origin of restrictions regarding technologies (e.g., biotechnologies: GMOs and, more recently, gene editing). The causes have already been analyzed in relation to European regulations, but not to its deeply embedded roots. This is what the present article attempts to do. It first depicts the broader historical background in Europe, the rise of a new ideology aiming to avoid repetition of the tragedies of the past, and the way these postmodern ideas have been transposed to science, with a focus on the issue of technological risk. In contrast to Europe, the United States has not enacted biotechnology-inhibiting laws, and the reasons for such a difference are discussed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681002 | PMC |
http://dx.doi.org/10.3389/fbioe.2020.557115 | DOI Listing |
Nat Commun
January 2025
Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, Australia.
Cas12a is a next-generation gene editing tool that enables multiplexed gene targeting. Here, we present a mouse model that constitutively expresses enhanced Acidaminococcus sp. Cas12a (enAsCas12a) linked to an mCherry fluorescent reporter.
View Article and Find Full Text PDFWorld J Microbiol Biotechnol
January 2025
Zybio Inc, Chongqing, 400082, China.
Lipase (EC 3.1.1.
View Article and Find Full Text PDFGene
January 2025
Cancer and Stem Cell Biology Laboratory, Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, TamilNadu 603203, India. Electronic address:
Cancer is considered the second most common disease globally. In the past few decades, many approaches have been proposed for cancer treatment. One among those is targeted therapy using CRISPR-Cas system which plays an irreplaceable role in translational research through gene editing.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
February 2025
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.
The ionizable lipid component of lipid nanoparticle (LNP) formulations is essential for mRNA delivery by facilitating endosomal escape. Conventionally, these lipids are synthesized through complex, multistep chemical processes that are both time-consuming and require significant engineering. Furthermore, the development of new ionizable lipids is hindered by a limited understanding of the structure-activity relationships essential for effective mRNA delivery.
View Article and Find Full Text PDFCirc Res
January 2025
Department of Integrative Physiology (W.G.P., J.F.M.), Baylor College of Medicine, Houston, TX.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!